Release Date: Oct 2019
CC: PC, MK, PBL
Gary W. Procop, MD, MS M(ASCP)
Medical Director, Medical Operations Director, Mycology, Virology, Parasitology, and Molecular Microbiology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH; Professor of Pathology; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University; Cleveland, OH
Learning Objectives:
After completing this course, participants will be able to:
-
Identify Rasamsonia to the genus level and explain the importance of identification with respect to antifungal resistance patterns.
-
Recommend and explain the optimal method for the detection of Pneumocystis jirovecii from respiratory specimens.
-
Recommend the optimal use of Histoplasma antigen testing and broad-range fungal PCR, and explain the drawbacks of inappropriate utilization.
Who should attend? Practicing Pathologists, Infectious Diseases Physicians, Residents, Doctoral Scientists, Laboratory Managers, Bench Supervisors, Students
Description:
This webcast course will discuss what is expected from the microbiologist, mycologist, and/or infectious disease histopathologist regarding the diagnosis of fungal infections. Two recently characterized fungi of medical importance under the “What’s New in Mycology” category will be discussed. Some shortcomings or challenges in the diagnosis of fungal infections will be described, which is done in an effort to stimulate research and development in these areas. The session will conclude with a review of three recent studies that impact the practice of medical mycology as follows: